Table of Contents Author Guidelines Submit a Manuscript
International Journal of Photoenergy
Volume 2014, Article ID 436463, 8 pages
http://dx.doi.org/10.1155/2014/436463
Research Article

Photoprotective Effect of the Plant Collaea argentina against Adverse Effects Induced by Photodynamic Therapy

Centro de Investigaciones sobre Porfirinas y Porfirias (CIPYP), CONICET, Hospital de Clínicas José de San Martín, Universidad de Buenos Aires, Córdoba 2351 1er subsuelo, Ciudad de Buenos Aires, 1120AAF Buenos Aires, Argentina

Received 1 November 2013; Revised 10 January 2014; Accepted 12 January 2014; Published 27 February 2014

Academic Editor: Victor Loschenov

Copyright © 2014 Leandro Mamone et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Photodynamic therapy (PDT) is a treatment modality for tumours and other accessible lesions based on the combination of light and a photosensitizer (PS) accumulated in the target tissue. The main disadvantage of PDT is PS retention after treatment during long time periods that conduces to cutaneous damage. It is believed that singlet oxygen is responsible for that skin photosensitization. The aim of this work was to evaluate the photoprotective activity of the methanolic extract of the Argentinian plant Collaea argentina against PDT under several treatments and employing different PSs. C. argentina exhibited photoprotective activity against aminolevulinic acid- (ALA-) PDT in the LM2 murine adenocarcinoma cell line. The photoprotection was dependant on the extract concentration and the incubation time, being detectable from 40 μg/mL onwards and at least after 3 h exposure of the cells. C. argentina extract protects these mammalian tumor cells against PDT effects, and it interferes with the oxygen singlet production from PSs during PDT treatment. We propose that it will be a promising agent to protect cells against PDT-induced skin sensitivity.

1. Introduction

Photodynamic therapy (PDT) is a treatment modality for tumors and other accessible lesions. It is based on the combination of light and a photosensitizer (PS), which is a light-sensitive drug selectively accumulated in the target tissue [1].

It is widely accepted that photosensitivity is primarily caused by the production of reactive oxygen species (ROS). The cytotoxic effect of these species, through its reaction with cellular targets such as proteins, lipids, and DNA, is the rationale for the use of PDT in the treatment of cancer. Most clinical work on PDT has been carried out employing Photofrin, Temoporfin, or Verteporfin, that is, porphyrin derivatives.

5-Aminolevulinic acid (ALA) has also been successfully used as a tool for the photodiagnosis [2] and PDT of neoplastic tissue [3]. While ALA itself is neither fluorescent nor a photosensitiser, it can induce the biochemical formation of protoporphyrin IX (PpIX). Two molecules of ALA are converted into porphobilinogen, reaction mediated by porphobilinogen synthase, and 5 other enzymes, 3 cytosolic and 2 mitochondrial, which lead to the formation of PpIX, which is a very efficient photosensitizer. Photodynamic action of PpIX is mainly induced by the generation of singlet oxygen in a type II photodynamic reaction [4].

ALA and other PSs currently employed in clinical PDT, such as Verteporfin and Temoporfin, produce singlet oxygen during the light exposure and in addition all the PSs are retained in other sites other than the tumor, thus inducing skin photosensitivity [47].

Photodynamic activity of certain plant components was first described about one hundred years ago. Bleaching of laundry on a lawn may be the earliest practical application of photodynamic activity. Chlorophyll, the green plant pigment, plays the main role in the production of this photodynamic action and, as well as some of its derivatives, it is used as a photosensitizer in PDT [8]. In addition, the anthraquinone, Hypericum perforatum extract, has recently been developed as a novel and natural PS for use in PDT of cancer. An analysis of a number of chemotherapeutic agents and their sources reveals that over 60% of approved drugs are derived from natural compounds [9].

Argentina has an abundant and diverse flora ranging from subarctic to subtropical climates; however, the medicinal properties of these plants have not been fully exploited. In previous work, we have carried out a screening of Argentinian plants in the search of new photosentizers (PSs) [10].

All the methanolic leaf extracts showed photoactivity due to their chlorophyll or their derivatives content [10]. However, the extract of C. argentina leaves did not induce photodamage. Since this extract contains chlorophyll and its derivatives, we hypothesised that this lack of photosensitization could be due to the presence of photoprotective compounds. The aim of this work was to evaluate the photoprotective activity of C. argentina leaf extract against PDT under several conditions using different PSs.

2. Materials and Methods

2.1. Chemicals

ALA and 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazoliumbromide (MTT) were obtained from Sigma-Aldrich (Poole, UK). Verteporfin was obtained from Conifarma, Argentina. Temoporfin was obtained from Biolite Pharma (Ireland, UK). The rest of the chemicals employed were of analytical grade. Chlorin e6 was from Frontier Scientific, USA, and Toluidine blue was from Merck.

2.2. Cell Line and Cell Culture

The cell line LM2 was derived from a spontaneous murine mammary adenocarcinoma of BALB/c mice. It was obtained from Instituto Roffo, Buenos Aires, Argentina [11]. The cells were cultured in RPMI 1640 medium, supplemented with 2 mM L-glutamine, 80 μg/mL gentamycin, and 5% fetal bovine serum and were maintained in a humidified atmosphere of 5% CO2 at 37°C.

2.3. Plant Material

Collaea argentina Griseb. (BAA 2664) was collected from the Botanical Garden Lucien Hauman of the Agronomy School, University of Buenos Aires, and was identified by Ing. Agr. Juan Manuel Valla. A voucher specimen is kept in the herbarium of the mentioned institution. Plant nomenclature is according to Zuloaga et al. [12].

2.4. Extraction Procedure

Fresh leaves of C. argentina (100 to 200 g) were washed with distilled water, dried, and homogenized in absolute methanol. Methanolic extracts of C. argentina were filtered and evaporated under reduced pressure using a rotary evaporator and lyophilized afterwards to remove any traces of solvent. The obtained yields were 3% to 5%, and the resulting powders were stored at −20°C.

2.5. PDT Treatment

The cells were exposed to the different PSs (1 mM ALA, 3 mM Verteporfin, or 3 mM Temoporfin) in medium without serum. After 3 h exposure, the cells were irradiated for different time periods employing a light source located below the plate, at a distance of 20 cm. Afterwards, the medium was replaced by medium containing serum and the plates were incubated for 19 hours at 37°C and the MTT assay was performed.

The light source employed was a bank of two fluorescent lamps (Osram L 36W/10). The spectrum of the light is between 400 and 700 nm with the highest radiant power at 600 nm. Fluence rate was measured with a Yellow Springs Kettering model 65 radiometer (Yellow Springs, OH, USA). We used fluences between 0 and 38 mJ/cm2, corresponding to 0 to 10 min of irradiation.

2.6. Photoprotection Experiments

To test the possible photoprotective activity of C. argentina, the cells were plated at  cells/mL and 24 h afterwards, and they were exposed to different concentrations of C. argentina, before, during, and/or after PDT, according to Figure 1. C. argentina cytotoxicity (CIXX) was defined as the concentration to kill XX% of cells.

436463.fig.001
Figure 1: Scheme of the different treatments designed to evaluate the photoprotective effect of C. argentina.
2.7. Singlet Oxygen Production

To detect singlet oxygen (1O2), the shift of fluorescence of the fluorescent marker “Singlet Oxygen Sensor Green” (Invitrogen, USA) was used. The probe was added to the PSs solutions in PBS and the mixtures were irradiated with a 635 nm Lumiia Laser system (Buenos Aires, Argentina) coupled to a fibre optic at 500 W during different times, ranging from 2 to 10 min. The fluorescent product was quantified at 504 and 525 nm excitation and emission wavelengths, respectively, in a Perkin Elmer LS55 fluorometer (UK). C. argentina + PS mixtures kept in dark were employed as controls.

2.8. MTT Viability Assay

Cytotoxicity and phototoxicity were documented by the MTT assay [13], a method based on the activity of mitochondrial dehydrogenases. Following appropriate treatments, MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazoliumbromide) solution was added to each well in a concentration of 0.5 mg/mL, and plates were incubated at 37°C for 1 h. The resulting formazan crystals were dissolved by the addition of DMSO and absorbance was read at 560 nm.

2.9. Statistical Treatment

The values in the figures and tables are expressed as means ± standard deviations of the means. A two-tailed Student’s t-test was used to determine statistical significance between means. values are considered significant.

3. Results

In the first stage, we attempted to assess C. argentina dark toxicity under the different treatments (A to D), and it was known that the methanolic extract of C. argentina leaf is slightly toxic to LM2 cells under darkness (CI50  56 ± 5 μg/mL) [14].

Figure 2 shows cytotoxic effects of C. argentina under darkness (0 min irradiation). During Treatment A, at low concentrations of C. argentina (10 and 20 μg/mL), the toxicity per se was less than 20%, and at higher concentrations (40 and 70 μg/mL) C. argentina toxicity is proportionally increased to 41% and 75%, respectively. In Treatment B, the extract exhibits less cytotoxicity since incubation time was decreased. In Treatment C, C. argentina cytotoxicity is negligible since incubation time is only 10 min. Treatment D shows the highest cytotoxicity employing the highest concentrations (40 and 70 μg/mL). Treatment E involves the longest incubation time in the presence of the extract, thus showing even more marked viability decrease. To sum up, cell viability decreases as a function of the incubation time and the concentration of C. argentina.

436463.fig.002
Figure 2: Cytotoxicity per se of C. argentina extract in LM2 cells. LM2 cells were incubated with C. argentina during different time periods according to each treatment described in Section 2. Cell death is referred as percentage of the nontreated control.

In the second stage, we evaluated the effect of C. argentina extract to abrogate ALA-PDT induced phototoxicity in LM2 cells (Figure 3), employing ALA-PDT conditions taken from previous work [15].

fig3
Figure 3: Photoprotective assays of C. argentina extract against ALA-PDT in LM2 cells. ALA-PDT was performed employing 0.6 mM ALA, 3 h of incubation, and different irradiation times. ((a)–(e)) correspond to the different protocols employed, as explained in Section 2. Cell viability was expressed as percentage of the control without irradiation.

C. argentina extract was added 24 h before photodynamic treatment to allow cell incorporation and during ALA-PDT (Treatment A), during ALA-PDT (Treatment B), just during the irradiation (Treatment C), after ALA-PDT (Treatment D), and before, during, and after ALA-PDT (Treatment E).

Figure 3 shows phototoxicity of ALA-PDT in the presence of C. argentina, normalized to the nonirradiated control. At low concentrations (10 and 20 μg/mL) of C. argentina under Treatment A showed no protection against ALA-PDT, but when C. argentina concentration was increased to 70 µg/mL, the percentage of living cells did not change upon irradiation, thus suggesting a protective effect against photosensitization.

When C. argentina was added only during ALA-PDT treatment (Treatment B), the photoprotection obtained was lower than that observed for Treatment A. The effect was more marked at high extract concentrations, and they increased the amount of light dose necessary to induce a certain percentage of cell death. That is, ALA-PDT with 10 min of irradiation induced 98% of cell death in absence of C. argentina, whereas in the presence of C. argentina, 40 µg/mL and 70 µg/mL, the values decreased to 70% and 40%, respectively ().

When C. argentina was added just during the irradiation (Treatment C), the incubation time with the cells was not enough to allow photoprotection in all the concentration range, showing only a slight protection at the highest concentrations, achieving 83% and 79% of cell death employing 40 µg/mL and 70 µg/mL, respectively, versus 98% of the control ().

When the extract was added after ALA-PDT and withdrawn just before MTT viability assay (Treatment D), photoprotection was not observed in all the concentration range of C. argentina.

In addition, when the incubation was performed before, during, and after ALA-PDT with C. argentina (Treatment E), the photoprotective effect was observed again, at the highest concentrations of C. argentina, leading only to 31% and 26% of cell death at 40 µg/mL and 70 µg/mL, respectively, as compared to 98% of the control ().

Throughout the experiments, we noticed that the highest concentrations of C. argentina, the highest photoprotection indexes, independently on the treatment, employed.

We defined a photoprotection index, which allowed us to compare the protection of each treatment, independently on C. argentina cytotoxity (Table 1). Indexes around 1 denote photoprotection, since they suggest no phototoxicity, whereas values around 0 indicate no protection at all. Those indexes let us know the best conditions to continue with our studies. We considered that Treatment A (incubation before and during ALA-PDT) and 40 μg/mL of C. argentina would be the best condition, since we obtained the higher photoprotective effect with the lower extract cytotoxicity.

tab1
Table 1: Photoprotection indexes of C. argentina against ALA-PDT in LM2 cells after 10 min of irradiation.

Tryptophan is a well-known singlet oxygen scavenger and is a photoprotective compound against ALA-PDT [15]. We decided to compare the effect of tryptophan with the one excerpted by C. argentina under Treatment A. Figure 4 shows that tryptophan induces slight dark toxicity (CI10 for 8 mM Tryptophan), and at that concentration, it abrogated ALA-PDT effect completely. That protection was stronger than the one obtained from C. argentina.

436463.fig.004
Figure 4: ALA-PDT of LM2 cells in the presence of C. argentina methanolic extract or tryptophan. Cells were subjected to ALA-PDT with 0.6 mM ALA, 3 h of incubation, and then 10 min of irradiation, in the presence of either 40 µg/mL C. argentina or 8 mM tryptophan (Treatment A). Viability was expressed as percentage of the control without treatment .

With the aim to know if the photoprotective effect was exclusive to ALA-PDT or if it was independent on the PS used, we evaluated the photoprotection of C. argentina against PDT with the other two PSs of clinical use, Verteporfin and Temoporfin which produce singlet oxygen as the main ROS [4, 6, 7]. Figure 5 shows the effect of C. argentina against PDT under different schemes and extract concentrations. At low concentrations (10 and 20 μg/mL) it was not possible for the extract to excerpt photoprotection against Verteporfin or Temoporfin-PDT.

fig5
Figure 5: Photoprotection assays of C. argentina against Verteporfin and Temoporfin-PDT. LM2 cells were incubated 3 h with 3 mM Verteporfin (a) or 3 mM Temoporfin (b), and C. argentina was added before and during PDT (Treatment A). Viability was expressed as percentage with respect to the nonirradiated control.

Employing 40 μg/mL and 70 µg/mL of the extract, a photoprotective effect against PDT with both PSs was observed. The highest photoprotection was excerpted against Verteporfin-PDT, at similar rates as compared to ALA-PDT. Cell death was reduced to 18%, which is significantly higher than 92% observed in the control of Verteporfin-PDT without extract. For Temoporfin-PDT, similar results were obtained, but achieving lower rates of photoprotection.

When we compared the photoprotective indexes of C. argentina against ALA, Verteporfin, or Temoporfin-PDT, we can observe that the highest indexes were obtained against ALA-PDT (Table 2).

tab2
Table 2: Photoprotection indexes of ALA, Verteporfin, and Temoporfin-PDT in LM2 cells.

With the aim to test possible interferences of C. argentina with 1O2 production during PDT, we employed Toluidine blue and Chlorin e6 as well-known PSs to induce a high singlet oxygen production (Figure 6). A dramatic decrease of 1O2 production was observed in the presence of C. argentina, showing a direct relationship with the scavenging activity of the extract.

436463.fig.006
Figure 6: C. argentina as scavenger of singlet oxygen produced by Toluidine blue and Chlorin e6-PDT. Singlet oxygen production was quantified using a fluorescent specific probe at different times of PDT employing Toluidine blue and Chlorin e6 as photosensitizers.

4. Discussion

C. argentina protected the murine LM2 adenocarcinoma cell line against PDT damage. The photoprotection was dependant on the extract concentration and the incubation time, being detectable from 40 μg/mL onwards, and at least 3 h of cell exposure. Since per se cytotoxicity of the extract interferes with the analysis of the results, it was necessary to determine the best conditions to perform the studies, seeking the highest photoprotection with the lowest cytotoxicity. The best conditions were 40 μg/mL of C. argentina methanolic extract and 24 h incubation before PDT and during PDT treatment.

Extract concentrations lower than 40 μg/mL were less toxic but, however, they did not induce photoprotection. The highest concentration employed was 70 μg/mL, and even when the photoprotection was higher, per se cytotoxicity of C. argentina was extremely high (CI75).

In terms of incubation time, the strongest photoprotective effects were observed at the longest incubation times, and those are 24 and 48 h. However, 48 h incubation resulted in extremely high cytotoxicity. When the extract was added just during the irradiation or after PDT treatment, no protection was observed, thus allowing us to think that the potential photoprotective compound needs longer incubation times to be taken up by the cells. This observation agrees with a previous work of our group [15] where compounds like L-tryptophan, N-acetyl-L-cystein, melatonin, L-methionine, L-cystein, mannitol, and glycine incubated before and during PDT treatment showed the best photoprotective effects. The photoprotection of C. argentina was comparable with that of tryptophan, which is a well-known oxygen singlet scavenger [15].

C. argentina protection against Verteporfin and Temoporfin-PDT was also observed at a lesser extent as compared to ALA-PDT. PpIX from ALA and Verteporfin are accumulated mainly in mitochondria and plasma membrane. Verteporfin in addition is accumulated in the endoplasmatic reticle. Temoporfin accumulates in Golgi apparatus, endoplasmatic reticle, and at minor levels, in mitochondria [1618]. The highest photoprotection against ALA and Verteporfin-mediated PDT may be related to their subcellular localization sites.

Not always the antioxidant defenses can cope with the entire PDT damage. It was reported that nasopharyngeal tumor cells that overexpress metallothioneins, which act as free radicals scavengers, were overcome by hypericin-PDT. Hypericin is a PS extract from a plant, which produces and 1O2, and upon irradiation induces necrosis in the mentioned cells [19].

Few authors reported photoprotection against PDT. Nitroimidazoles were found to be photoprotectors against PDT using Photofrin, in the emt-6 mammalian murine tumor cell line [20]. In vivo studies demonstrated that 1,3 diphenyl-benzofuran and tryptophan were photoprotective compounds in rats treated with PDT using hematoporphyrin as PS [21].

A disadvantage of PDT is the PS retention in sites other than tumor during long time periods after treatment, even weeks, which induces skin photosensitivity. In vitro and in vivo studies describe that singlet oxygen is responsible for cutaneous photosensitization. It is highly important to find compounds to reduce adverse effects of PDT.

Plants have biochemical systems that attenuate the harmful effects of reactive oxygen species, in particular those generated during the photosynthesis, and xanthophylls and carotenoids account for these antioxidant defenses involved. Other compounds are able to synthesize molecules which respond to biotic and abiotic stress, commonly called secondary metabolites. Some of these compounds have been reported as photoprotectors and/or antioxidants. Beta-carotene and flavonoids usually are in chloroplast membranes to protect the damage caused by 1O2, in a particular way to protect against lipid photoperoxidation. Scavenger effects of lipid plant extracts against 1O2 were detected [22].

Polyphenols synthesized in higher plants, in response to stress, constitute also part of their antioxidant defense system [23]. Curcumin extracted from Curcuma longa is able to inhibit the apoptosis generated by oxidant damage of 1O2 during PDT treatment in A431 epidermoid carcinoma cells [24].

UV and psoralen therapy is a kind of photochemotherapy which uses UV radiation instead of visible light as it is used in PDT. The use of plant extracts for UV protection is wildly known. The extract of Polypodium leucotomos administrated orally or topically, resulted in photoprotection in Langerhans cells against UV and psoralens employed in vitiligo treatment [25].

Employing qualitative tests to identify organic molecule functional groups, we detected the presence of anthraquinones, saponins, carbohydrates, and tanins in C. argentina extract. However, we do not know the exact composition of C. argentina and its relationship with its photoprotective properties.

To sum up, our results indicate that C. argentina extract protects mammalian tumor cells against PDT effects, and it interferes with singlet oxygen production during photodynamic treatment. We propose this will be a promising agent to protect skin from adverse photosensitivity. It is our hope to continue this work with in vivo studies and purification of the extract with the aim to isolate the compound responsible for the photoprotection and further studies in normal skin tissue are needed to ascertain that the plant C. argentina may be employed in the prevention from side effects caused by PDT. Our findings would be useful in the design of ointments to protect normal skin against the undesirable effects of PDT.

Abbreviations

ALA:5-Aminolevulinic acid
MTT:3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazoliumbromide
PDT:Photodynamic therapy
PpIX:Protoporphyrin IX
PS:Photosensitizer
PSs:Photosensitizers.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgments

This research was supported by the CONICET, the Science and Technology Argentine Agency PICT 06-1809, PICT 08-0047, and the Asociación Cooperadora Hospital de Clínicas Gral José de San Martín. L. Mamone is a Fellow of Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET).

References

  1. T. J. Dougherty, “Photodynamic therapy (PDT) of malignant tumors,” Critical Reviews in Oncology and Hematology, vol. 2, no. 2, pp. 83–116, 1984. View at Google Scholar · View at Scopus
  2. R. Baumgartner, R. M. Huber, H. Schulz et al., “Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer,” Journal of Photochemistry and Photobiology B, vol. 36, no. 2, pp. 169–174, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. J. C. Kennedy, R. H. Pottier, and D. C. Pross, “Photodynamic therapy with endogenous protoporphyrin. IX: basic principles and present clinical experience,” Journal of Photochemistry and Photobiology B, vol. 6, no. 1-2, pp. 143–148, 1990. View at Google Scholar · View at Scopus
  4. B. Liu, T. J. Farrell, and M. S. Patterson, “A dynamic model for ALA-PDT of skin: simulation of temporal and spatial distributions of ground-state oxygen, photosensitizer and singlet oxygen,” Physics in Medicine and Biology, vol. 55, no. 19, pp. 5913–5932, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. R. R. Allison, G. H. Downie, R. Cuenca, X.-H. Hu, C. J. H. Childs, and C. H. Sibata, “Photosensitizers in clinical PDT,” Photodiagnosis and Photodynamic Therapy, vol. 1, no. 1, pp. 27–42, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Hu, N. Zeng, Z. Liu et al., “Two-dimensional singlet oxygen imaging with its near-infrared luminescence during photosensitization,” Journal of Biomedical Optics, vol. 16, no. 1, Article ID 016003, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. E. B. Gyenge, D. Lüscher, P. Forny et al., “Photodynamic mechanisms induced by a combination of hypericin and a chlorin based-photosensitizer in head and neck squamous cell carcinoma cells,” Photochemistry and Photobiology, vol. 89, no. 1, pp. 150–162, 2013. View at Publisher · View at Google Scholar
  8. R. Ebermann, G. Alth, M. Kreitner, and A. Kubin, “Natural products derived from plants as potential drugs for the photodynamic destruction of tumor cells,” Journal of Photochemistry and Photobiology B, vol. 36, no. 2, pp. 95–97, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. G. M. Cragg, D. J. Newman, and K. M. Snader, “Natural products in drug discovery and development,” Journal of Natural Products, vol. 60, no. 1, pp. 52–60, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Mamone, A. Casas, L. Rodriguez, L. Gándara, A. Batlle, and G. di Venosa, “Estudios in vitro de extractos de plantas autóctonas argentinas como potenciales antineoplásicos o fotosensibilizantes en la Terapia Fotodinámica del cáncer,” Medicina Buenos Aires, vol. 70, pp. 125–126, 2010. View at Google Scholar
  11. S. E. Werbajh, A. J. Urtreger, L. I. Puricelli, E. S. de Lustig, E. Bal de Kier Joffé, and A. R. Kornblihtt, “Downregulation of fibronectin transcription in highly metastatic adenocarcinoma cells,” The FEBS Letters, vol. 440, no. 3, pp. 277–281, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. F. O. Zuloaga, O. Morrone, and M. Belgrano, Catálogo de Plantas Vasculares del Cono Sur, vol. 1, 2009.
  13. F. Denizot and R. Lang, “Rapid colorimetric assay for cell growth and survival—modifications to the tetrazolium dye procedure giving improved sensitivity and reliability,” Journal of Immunological Methods, vol. 89, no. 2, pp. 271–277, 1986. View at Google Scholar · View at Scopus
  14. L. Mamone, G. di Venosa, J. J. Valla et al., “Cytotoxic effects of argentinean plant extracts on tumour and normal cell lines,” Cellular and Molecular Biology, vol. 57, pp. 1487–1499, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Perotti, A. Casas, and A. M. del C. Batlle, “Scavengers protection of cells against ALA-based photodynamic therapy-induced damage,” Lasers in Medical Science, vol. 17, no. 4, pp. 222–229, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. C. M. N. Yow, J. Y. Chen, N. K. Mak, N. H. Cheung, and A. W. N. Leung, “Cellular uptake, subcellular localization and photodamaging effect of Temoporfin (mTHPC) in nasopharyngeal carcinoma cells: comparison with hematoporphyrin derivative,” Cancer Letters, vol. 157, no. 2, pp. 123–131, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. L. D. Barnes, E. A. Giuliano, and J. Ota, “Cellular localization of Visudyne as a function of time after local injection in an in vivo model of squamous cell carcinoma: an investigation into tumor cell death,” Veterinary Ophthalmology, vol. 13, no. 3, pp. 158–165, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. A. D. Tekrony, N. M. Kelly, B. A. Fage, and D. T. Cramb, “Photobleaching kinetics of Verteporfin and Lemuteporfin in cells and optically trapped multilamellar vesicles using two-photon excitation,” Photochemistry and Photobiology, vol. 87, no. 4, pp. 853–861, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. H.-Y. Du, Y. Li, M. Olivo, G. W.-C. Yip, and B.-H. Bay, “Differential up-regulation of metallothionein isoforms in well-differentiated nasopharyngeal cancer cells in vitro by photoactivated hypericin,” Oncology Reports, vol. 16, no. 6, pp. 1397–1402, 2006. View at Google Scholar · View at Scopus
  20. R. Santus, C. C. Stobbe, M. S. McPhee, and J. D. Chapman, “Protection against light-activated photofrin II killing of tumor cells by nitroimidazoles,” Radiation Research, vol. 130, no. 1, pp. 31–37, 1992. View at Google Scholar
  21. N. D. Hogikyan, R. E. Hayden, and P. W. McLear, “1991Cutaneous photoprotection using a hydroxyl radical scavenger in photodynamic therapy,” American Journal of Otolaryngology, vol. 12, no. 1, pp. 1–5.
  22. R. Ferrari-Iliou, A. D'Arcy-Lamenta, J.-P. Iliou et al., “In vitro photodynamic lipid peroxidation of total lipophilic extracts from leaves of bean plants,” Biochimica et Biophysica Acta, vol. 1166, no. 1, pp. 48–54, 1993. View at Publisher · View at Google Scholar · View at Scopus
  23. L. G. Korkina, S. Pastore, E. Dellambra, and C. de Luca, “New molecular and cellular targets for chemoprevention and treatment of skin tumors by plant polyphenols: a critical review,” Current Medicinal Chemistry, vol. 20, no. 7, pp. 852–868, 2013. View at Google Scholar
  24. W.-H. Chan and H.-J. Wu, “Anti-apoptotic effects of curcumin on photosensitized human epidermal carcinoma A431 cells,” Journal of Cellular Biochemistry, vol. 92, no. 1, pp. 200–212, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. S. González, M. A. Pathak, J. Cuevas, V. G. Villarrubia, and T. B. Fitzpatrick, “Topical or oral administration with an extract of Polypodium leucotomos prevents acute sunburn and psoralen-induced phototoxic reactions as well as depletion of Langerhans cells in human skin,” Photodermatology Photoimmunology and Photomedicine, vol. 13, no. 1-2, pp. 50–60, 1997. View at Google Scholar · View at Scopus